...
首页> 外文期刊>Analytical Chemistry >Array-Based Analysis of Secreted Glycoproteins for Rapid Selection of a Single Cell Producing a Glycoprotein with Desired Glycosylation
【24h】

Array-Based Analysis of Secreted Glycoproteins for Rapid Selection of a Single Cell Producing a Glycoprotein with Desired Glycosylation

机译:分泌型糖蛋白的基于阵列的分析,用于快速选择产生具有所需糖基化糖蛋白的单细胞

获取原文
获取原文并翻译 | 示例

摘要

The therapeutic efficacy and in vivo biological function ofna glycoprotein is significantly affected by its glycosylationnprofile. For the development of glycoproteins with therapeuticnapplications, selection of cell lines producing anglycoprotein with adequate glycoform is crucial. Here, wendemonstrate an array-based analysis of secreted glycoproteinsnfor rapid and efficient selection of a single cellnproducing a glycoprotein with desirable glycosylation. Ournapproach relies on microengraving and interrogation ofnglycoproteins produced by individual cells in a microwellnarray in terms of glycosylation profile as well as thenproduced amount. On the basis of statistical analysis ofnthe interrogation, single cells which are predicted tonproduce a desired glycoprotein are selected, retrieved,nand expanded. We applied the approach to human recombinantnerythropoietin (rhEPO)-producing CHO cellsnand verified the selection of a single CHO cell thatnproduces rhEPO with a high sialylation degree. Humannerythropoietin (hEPO) bearing highly sialylated oligosaccharidenwas shown to display a much longer plasma halflife,nresulting in high therapeutic efficacy. This methodnmay find widespread use in the clonal selection for thenproduction of other glycoproteins with specific glycosylationnas well as analysis of the heterogeneity in cellnpopulations in a high-throughput manner.
机译:糖蛋白的糖基化作用显着影响糖蛋白的治疗功效和体内生物学功能。对于具有治疗应用的糖蛋白的开发,选择产生具有足够糖型的糖蛋白的细胞系是至关重要的。在这里,我们将对分泌的糖蛋白进行基于阵列的分析,以便快速,有效地选择产生具有所需糖基化糖蛋白的单个细胞。我们的方法依赖于微孔板阵列中单个细胞产生的糖蛋白的微刻和询问,糖蛋白化谱图以及产生的量均如此。在对询问进行统计分析的基础上,选择,检索和扩展预测会产生所需糖蛋白的单个细胞。我们将这种方法应用于人类重组促红细胞生成素(rhEPO)产生的CHO细胞,并验证了选择单个产生唾液酸化程度高的rhEPO的CHO细胞的选择。携带高度唾液酸化寡糖的人类促红细胞生成素(hEPO)已显示出更长的血浆半衰期,因此具有很高的治疗功效。该方法可广泛用于克隆选择,然后生产具有特定糖基化酶的其他糖蛋白,并以高通量的方式分析细胞群中的异质性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号